Clinical Trial

Impact of Metabolic Health on Sperm Epigenetic Marks in Humans

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 6, 2026 (before its estimated July 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study is designed to evaluate whether epigenetic markers in overweight men with type 1 diabetes (T1D) or type 2 diabetes (T2D) can be improved with a 3 month lifestyle intervention or program focused in glycemic intervention.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2019-02-28; most recent amendment 2026-02-04.
Status change: Recruiting → Active, Not Recruiting 2026-02-04
Trial Details
NCT Number NCT03860558
Lead Sponsor Joslin Diabetes Center
Conditions Overweight, Type 2 Diabetes Mellitus, Type 1 Diabetes Mellitus
Enrollment 40 participants
Start Date 2018-05-01
Primary Completion 2026-07-01 (estimated)
Study Completion 2026-07-01 (estimated)
Updated on ClinicalTrials.gov 2026-02-06